179 related articles for article (PubMed ID: 28887057)
1. PPARγ agonists: Potential treatments for exudative age-related macular degeneration.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2017 Nov; 188():123-130. PubMed ID: 28887057
[TBL] [Abstract][Full Text] [Related]
2. Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
J Mol Neurosci; 2017 Aug; 62(3-4):368-379. PubMed ID: 28689265
[TBL] [Abstract][Full Text] [Related]
3. Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway.
Vallée A; Lecarpentier Y; Vallée R; Guillevin R; Vallée JN
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012797
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and Wnt/β‑catenin signaling in exudative age‑related macular degeneration (Review).
Vallée A
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35445729
[TBL] [Abstract][Full Text] [Related]
6. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
[TBL] [Abstract][Full Text] [Related]
7. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Vallée JN; Lecarpentier Y
Mol Psychiatry; 2019 May; 24(5):643-652. PubMed ID: 30104725
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.
Vallée A; Lévy BL; Blacher J
Curr Hypertens Rep; 2018 Jun; 20(7):62. PubMed ID: 29884931
[TBL] [Abstract][Full Text] [Related]
9. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Cell Mol Neurobiol; 2018 May; 38(4):783-795. PubMed ID: 28905149
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ.
Vallée A; Vallée JN; Lecarpentier Y
J Mol Cell Cardiol; 2019 Aug; 133():36-46. PubMed ID: 31153873
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment.
Vallée A; Lecarpentier Y; Vallée JN
Front Immunol; 2021; 12():666693. PubMed ID: 33927728
[TBL] [Abstract][Full Text] [Related]
12. Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration.
Qiu F; Liu Z; Zhou Y; He J; Gong S; Bai X; Zeng Y; Liu Z; Ma JX
Sci Rep; 2017 Apr; 7(1):1263. PubMed ID: 28455497
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling in age-related macular degeneration: human macular tissue and mouse model.
Tuo J; Wang Y; Cheng R; Li Y; Chen M; Qiu F; Qian H; Shen D; Penalva R; Xu H; Ma JX; Chan CC
J Transl Med; 2015 Oct; 13():330. PubMed ID: 26476672
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
Vallée A; Lecarpentier Y; Vallée JN
Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
[TBL] [Abstract][Full Text] [Related]
15. Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neurosci Bull; 2018 Jun; 34(3):573-588. PubMed ID: 29582250
[TBL] [Abstract][Full Text] [Related]
16. [Age-related Macular Degeneration in the Japanese].
Yoshimura N
Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
18. WNT7A/B promote choroidal neovascularization.
Lin JB; Sene A; Wiley LA; Santeford A; Nudleman E; Nakamura R; Lin JB; Moolani HV; Apte RS
Exp Eye Res; 2018 Sep; 174():107-112. PubMed ID: 29864439
[TBL] [Abstract][Full Text] [Related]
19. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Lecarpentier Y; Vallée JN
J Exp Clin Cancer Res; 2019 Jul; 38(1):323. PubMed ID: 31331376
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
